BCL2 and malignant colon neoplasm: Furthermore, we identified numerous CTS transcriptional signatures whose expression was significantly associated with prognosis in colon cancer, such as CEBPB, PPARGC1, STAT3, MTOR, BCL2, JAK2, and CDK1.